Marshall Wace’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $241K | Buy |
61,719
+42,890
| +228% | +$167K | ﹤0.01% | 2260 |
|
2025
Q1 | $71.4K | Buy |
+18,829
| New | +$71.4K | ﹤0.01% | 2385 |
|
2023
Q4 | – | Sell |
-26,745
| Closed | -$69K | – | 1926 |
|
2023
Q3 | $69K | Buy |
+26,745
| New | +$69K | ﹤0.01% | 1745 |
|
2022
Q1 | – | Sell |
-10,031
| Closed | -$38K | – | 2755 |
|
2021
Q4 | $38K | Hold |
10,031
| – | – | ﹤0.01% | 2907 |
|
2021
Q3 | $40K | Sell |
10,031
-145,631
| -94% | -$581K | ﹤0.01% | 2324 |
|
2021
Q2 | $693K | Buy |
155,662
+79,695
| +105% | +$355K | ﹤0.01% | 1538 |
|
2021
Q1 | $695K | Buy |
75,967
+16,096
| +27% | +$147K | ﹤0.01% | 1524 |
|
2020
Q4 | $607K | Buy |
+59,871
| New | +$607K | ﹤0.01% | 1259 |
|